Moreover, survival analysis revealed that NPC patients with higher PXN‐AS1‐L expression levels have shorter survival time than those of NPC patients with lower PXN‐AS1‐L expression levels (Figure 1B). This evidence concerns the gene PXN and nasopharyngeal carcinoma.